Skip to main content
. 2020 Dec 17;1:100013. doi: 10.1016/j.lanepe.2020.100013

Table 4.

Adjusted prevalence of seropositivity to IgG antibodies against SARS-CoV-2 by categories of self-reported symptoms.

SARS-CoV-2 IgG seropositivity
N n % 95%CI
Symptoms category
 No symptoms 1089 36 2•4 1•4–3•6
 Atypical symptoms 77 5 5•7 1•6–13•9
 Mild symptoms 3247 341 9•8 8•7–10•9
 Moderate symptoms 331 72 21•4 16•9–26•3

95%CI: 95% Confidence Intervals.